Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $3,497 - $4,088
109 New
109 $3.62 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $5,071 - $6,013
109 New
109 $6,000
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $3,486 - $4,981
-129 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $1,786 - $2,317
-55 Reduced 29.89%
129 $5,000
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $1,368 - $1,536
-37 Reduced 16.74%
184 $8,000
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $461 - $526
-12 Reduced 5.15%
221 $10,000
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $1,053 - $1,221
-33 Reduced 12.41%
233 $8,000
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $24,080 - $25,549
-724 Reduced 73.13%
266 $10,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $217 - $239
7 Added 0.71%
990 $35,000
Q2 2017

Aug 14, 2017

BUY
N/A
983
983 $33,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Thomas J. Herzfeld Advisors, Inc. Portfolio

Follow Thomas J. Herzfeld Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.